| Code | 98937 | ||||||||||
| MA number | 50/0149/02-S | ||||||||||
| Product Form: | tbl 10x250 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PP/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 26.07.2002 |
| SPC: |
SPC_FURORESE 250_tbl_08_2024.pdf
|
| PIL: |
PIL_FURORESE 250_tbl_08_2024.pdf
|
| Safety feature | Yes |
| Data update: | 08.01.2018 |
